Validity and Reliability of Specific Test of Early Infant Motor Performance (STEP) Version 3.0
Investigation of the Turkish Validity and Reliability of Specific Test of Early Infant Motor Performance (STEP) in Follow-Up of Risk Infants
1 other identifier
observational
30
1 country
1
Brief Summary
Cerebral palsy and other neuromotor disorders are more common in babies born preterm (\<37 weeks of gestation), due to various biological and environmental risk factors and the risk increases as the gestational age decreases. Earlier and more frequent screening with the use of developmental skills tests facilitates referral to early intervention programs. Current guidelines recommend using some combination of neuroimaging and neurological examination and assessments such as neonatal imaging, general movements (GMs), and Hammersmith Infant Neurological Examination (HINE) for early diagnosis and intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2022
CompletedFirst Submitted
Initial submission to the registry
November 14, 2022
CompletedFirst Posted
Study publicly available on registry
November 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedDecember 27, 2022
October 1, 2022
11 months
November 14, 2022
December 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Specific Test of Early Infant Motor Performance (STEP) Version 3.0
The STEP test is a 10-item neurodevelopmental assessment that does not require special training, evaluating infants from term to corrected 3 months for rapid and early detection of motor problems. It evaluates the infant not only by the presence or absence of motor skills, but by the quality of movement. A term cut-off score of 16 or less and a three-month cut-off score of 22 or less are important criteria in developmental delay.
Change from term age of infants (40 weeks) to 3 month
Hammersmith Infant Neurological examination (HINE)
It is a neurodevelopmental assessment test accessible to all clinicians used for infants 2 to 24 months old. It is a 26-item test with a maximum score of 78 scored between 0-3. It has 3 sections: (1) neurological examination (26 items, scored) evaluating cranial nerve function, posture, movements, tone, reflexes, and reactions, (2) motor milestones (8 items, unscored), and (3) behaviour (3 items, unscored). Higher score indicates good neurological function.
Change from the baseline of the HINE score at corrected age 3, 6th month of infants
Bayley Scales of Infant and Toddler Development (BSID -III)
It is applied to evaluate the development in cognitive, language and movement areas in children whose corrected age is between 0-42 months. Movement scale consists of two parts as fine motor and gross motor. A score below 70 is a criterion for developmental delay.
Change from the baseline of the BAYLEY-III score at corrected age 6th month of infants
Study Arms (1)
preterm Infant
30 premature infants with a gestational age of 37 weeks and below and a history of stay in the neonatal intensive care unit will be evaluated.
Interventions
All infants at high risk of cp will be assessed by Specific Test of Early Infant Motor Performance (STEP) Version 3.0 at term age and at corrected age 3 months, by Hammersmith Infant Neurological Examination (HINE) a corrected age 3 and 6 months, also BAYLEY-III Infant and Toddler Development Assessment Scale (BAYLEY-III) at corrected 6 months.
Eligibility Criteria
A total of 30 infants will be included in the study. Based on the data of the previous study, the number of participants to be included in the study was found to be correlated with G\*Power 3.1.9.2 (Correlation: Bivariate) as p H1=0.89. The minimum number of individuals to be included in the sample of this study was calculated by taking effect size=0.60, α=0.05 and power=0.95, and it was found to be 30 in total. Since the effect size obtained from the sample study is large, it was preferred to use the correlation p H1=0.6 size in order to reach a larger sample size.
You may qualify if:
- Babies born before \<37 weeks of gestation and treated in the neonatal intensive care unit
- Infants with neurologic abnormalities (muscle hypertonia, hypotonia, hyperarousal, and abnormal general movements or cranial ultrasound abnormalities) at moderate to high risk of cerebral palsy
- Infants referred to physiotherapy due to motor developmental delay and neurological dysfunction
- Babies whose age range is between 0-12 months (corrected age will be calculated for premature babies)
- Being diagnosed as a neurologically and developmentally risky baby
- Babies who have completed medical treatments and are not in neonatal intensive care
- Infants of families of infants who agreed to participate in the study and approved the informed consent form
You may not qualify if:
- Babies with congenital cyanotic heart problems or cystic fibrosis
- Babies with genetic disease or congenital anomalies
- Infants on ventilator
- Babies of families who do not accept to work
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University Pendik Training and Research Hospital
Istanbul, 34899, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Evrim Karadag-Saygi, Prof
Marmara University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2022
First Posted
November 22, 2022
Study Start
January 18, 2022
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
December 27, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share